ShEEP Request for Nanostring nCounter Spring Profiler
ShEEP Request for Nanostring nCounter Spring Profiler
批准号:
9213421
负责人:
Robert Keith
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2016-09-30
关键词:
AgonistAlzheimer&aposs DiseaseAwardBioinformaticsBloodBrainCREB1 geneCellsComplementary DNAComputer softwareDNA SequenceDataData AnalysesDetectionDiseaseDoctor of PhilosophyFGFR1 geneFormalinGene ChipsGenetic TranscriptionGenomicsHandHead and Neck CancerK-Series Research Career ProgramsKynurenineLengthLibrariesMalignant NeoplasmsMalignant neoplasm of lungMarketingMethodsMolecular ProfilingNeoplasm MetastasisOncogenesOrganismPPAR gammaParaffin EmbeddingPathway interactionsPreparationPrincipal InvestigatorProcessProductivityRNARNA SequencesReactionRequest for ApplicationsResearchResearch InstituteResearch PersonnelResearch Project GrantsRoleSamplingSpecialistSystemTechnologyTimeToxoplasmaTrainingTubeTuberculosisVariantVeteransabstractingcancer chemopreventioncostdesignfaculty researchgenome-wideindividual patientinstrumentinterestnano-stringpersonalized medicineresponse biomarkersuicidal behaviortissue fixingtooltumor progressionuser-friendlywastingweb site
中文摘要
摘要
在本申请中,我们请求购买一台NanoStringnCounter Sprint Profiler仪器。这个
NCounter Sprint Profiler是一款用户友好、占用空间小、中等吞吐量的仪器,旨在检测
并对单个样本中多达800个不同的RNA或DNA序列进行量化。这项技术允许表达
在单个细胞或整个生物体中进行分析,旨在弥合单个qPCR之间的差距
反应和全球技术,如表达阵列或全基因组测序。这项技术
代表着基因组研究的一个重大进步,通过允许检测和量化数百个
与传统方法相比,靶序列的成本和时间要低得多。以下研究项目将是
受升级系统支持:
1)Robert Keith,医学博士,首席研究员:Blr&D功绩评审奖:肺的PPAR伽马激动剂
癌症的化学预防“
2)李华德,医学博士,首席研究员:BR&D职业发展奖《PPARGamma的角色》
在肺癌的进展和转移中
3)Nicholas Walter,医学博士,首席研究员:CSR&D职业发展奖《血液表达》
作为结核病反应生物标记物的概况“
4)Subbiah Pugazhenthi博士,首席研究员:BR&D功绩评审奖《CREB的机制》
阿尔茨海默病的大脑调节失调“
5)Lynn Heasley,博士,首席研究员:Blr&D功绩评审奖,FGFR1癌基因驱动因素
头颈部癌的途径
6)丽莎·布伦纳(Lisa Brenner),博士,CSR&D功绩评审奖联合首席研究员
犬尿氨酸途径与退伍军人的自杀行为
7)Edward Chan,医学博士,功绩评论和丹佛研究所首席研究员
英文摘要
Abstract
In this application we request the purchase of a Nanostring nCounter Sprint Profiler instrument. The
nCounter Sprint Profiler is a user friendly, small-footprint, medium throughput instrument designed to detect
and quantify up to 800 different RNA or DNA sequences in a single sample. This technology allows expression
analysis in a single cell or an entire organism and is designed to bridge the gap between single qPCR
reactions and global technologies like expression arrays or genome wide sequencing. This technology
represents a major advance in genomic research, by allowing detection and quantification of hundreds of
target sequences at much lower cost and time than traditional methods. The following research projects will be
supported by the upgrades system:
1) Robert Keith, MD, Principal Investigator: BLR&D Merit Review Award “PPAR gamma Agonists for Lung
Cancer Chemoprevention”
2) Howard Li, MD, Principal Investigator: BLR&D Career Development Award “The Role of PPARgamma
in Lung Cancer Progression and Metastasis”
3) Nicholas Walter, MD, Principal Investigator: CSR&D Career Development Award “Blood Expression
Profiles as a Biomarker for Responses to Tuberculosis”
4) Subbiah Pugazhenthi, PhD, Principal Investigator: BLR&D Merit Review Award “Mechanism of CREB
dysregulation in Alzheimer brain”
5) Lynn Heasley, PhD, Principal Investigator: BLR&D Merit Review Award “An FGFR1 oncogene driver
pathway in head and neck cancer”
6) Lisa Brenner, PhD, Co-Principal Investigator: CSR&D Merit Review Award “Toxoplasma gondi, the
kynurenine pathway, and suicidal behavior in veterans”
7) Edward Chan, MD, Principal Investigator, Merit Review and Denver Research Institute
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PPAR gamma Agonists for Lung Cancer Chemoprevention
-
批准号:8242628
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Robert Keith
-
依托单位:
PPAR gamma Agonists for Lung Cancer Chemoprevention
-
批准号:8047773
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Robert Keith
-
依托单位:
PPAR gamma Agonists for Lung Cancer Chemoprevention
-
批准号:8394610
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Robert Keith
-
依托单位:
PPAR gamma Agonists for Lung Cancer Chemoprevention
-
批准号:8922356
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Robert Keith
-
依托单位:
PPAR gamma Agonists for Lung Cancer Chemoprevention
-
批准号:9206065
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Robert Keith
-
依托单位:
PPAR gamma Agonists for Lung Cancer Chemoprevention
-
批准号:10058201
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Robert Keith
-
依托单位:
Clinical Trials Core
-
批准号:8664641
-
项目类别:
-
资助金额:$26.18万
-
财政年份:--
-
负责人:Robert Keith
-
依托单位:
Clinical Trials Core
-
批准号:9369733
-
项目类别:
-
资助金额:$28.37万
-
财政年份:--
-
负责人:Robert Keith
-
依托单位: